View Section: Cash Flow Statement
RE
Reata Pharmaceuticals IncNASDAQ RETA Stock Report
Last reporting period 30 Jun, 2023
Updated —
Last price
—
Market cap $B
6.566
Middle
Exchange
XNAS - Nasdaq
RE
Last reporting period 30 Jun, 2023
Updated —
Last price
—
Market cap $B
6.566
Exchange
XNAS - Nasdaq
RE
Ex-dividend date
Amount
Share price
Yield
This ticker has no dividend history